Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PJT Partners (PJT) Cash & Equivalents: 2014-2025

Historic Cash & Equivalents for Partners (PJT) over the last 11 years, with Sep 2025 value amounting to $400.5 million.

  • Partners' Cash & Equivalents rose 169.06% to $400.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $400.5 million, marking a year-over-year increase of 169.06%. This contributed to the annual value of $483.9 million for FY2024, which is 36.10% up from last year.
  • Latest data reveals that Partners reported Cash & Equivalents of $400.5 million as of Q3 2025, which was up 86.59% from $214.6 million recorded in Q2 2025.
  • In the past 5 years, Partners' Cash & Equivalents ranged from a high of $483.9 million in Q4 2024 and a low of $75.8 million during Q1 2022.
  • Moreover, its 3-year median value for Cash & Equivalents was $194.3 million (2025), whereas its average is $230.8 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 38.87% in 2023, then skyrocketed by 169.06% in 2025.
  • Partners' Cash & Equivalents (Quarterly) stood at $200.5 million in 2021, then dropped by 13.59% to $173.2 million in 2022, then soared by 105.24% to $355.5 million in 2023, then skyrocketed by 36.10% to $483.9 million in 2024, then surged by 169.06% to $400.5 million in 2025.
  • Its Cash & Equivalents stands at $400.5 million for Q3 2025, versus $214.6 million for Q2 2025 and $194.3 million for Q1 2025.